Atul Dandekar, CSBO at Maze Therapeutics, Inc. (MAZE), sold 7,500 shares at $27.31 ($205K) on 2026-07-29, disclosed to the SEC on 2026-07-31.
Scheduled sale ($205k) by CSBO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.31 | 7,100 | $194K | 94.6% |
| 2 | $27.89 | 400 | $11K | 5.4% |
| Total | $27.34 avg | 7,500 | $205K | 100% |
| Filing → |
| MAZE | SELL | 2026-08-31 | $207K | — | Filing → |
| MAZE | SELL | 2026-07-01 | $210K | — | Filing → |
| MAZE | SELL | 2026-06-02 | $198K | — | Filing → |